CORDIS - EU research results
CORDIS

Market Release of a Portable Device for COVID-19 at the Point-of-Care; a Global Diagnostics Approach

Project description

Portable device for COVID-19 real-time detection

As the world is bracing for the second wave of the rapidly spreading coronavirus, accurate diagnostic tools have emerged as a global priority. Together with isolation and tracking, the large-scale testing of citizens is proving to be most effective in controlling COVID-19. However, adequate, robust testing solutions are necessary to achieve fast results in protecting populations. For this reason, the EU-funded IRIS-COV project is proposing a solution based on a patented portable device with isothermal LAMP amplification and real-time, quantitative, colourimetric detection that has proven 97.4 % sensitive and 100 % specific for SARS-CoV-2 in samples. The project will validate and certify the portable device for COVID-19 and flu detection directly in crude samples and at the point of care, aiming towards its global uptake.

Objective

The current pandemic of the coronavirus, reported first on 31st December 2019 in China, has produced a global alert of unprecedented nature. From the beginning, immediate actions have been put in place by all relevant stakeholders, i.e. local health departments, governments, pharmaceutical companies, global organisations etc., to address the problem as quickly as possible and control the spread of the disease. Large scale testing of symptomatic and asymptomatic patients/citizens has been one of the most effective measures taken by several countries, combined with isolation and tracking. Today, after six months from the outbreak, the deaths continue to rise with over 200 affected countries. Fear of a new wave of the pandemic together with the ongoing cases worldwide make the need for developing rapid and accurate diagnostic tools for COVID-19 a global priority, as declared by the WHO. The current consortium aims to join forces in the battle against the coronavirus by producing mature and robust solutions with immediate impact. The proposal is built around the implementation of an existing and patented device and methodology based on isothermal LAMP amplification and real time quantitative colorimetric detection. This mature methodology, currently of a technology readiness level of 7, has already been proven to be able to detect SARS-CoV-2 in patients’ samples with 97.4% sensitivity and 100% specificity. The main objectives of this proposal are thus the immediate deployment of the device following clinical validation and fast track certification. Arrangements for the large-scale production of the device and reagents will take place in parallel, followed by the provision of a full medical certification for COVID-19 and flu detection directly in crude samples and at the point-of-care. Global uptake of the two certified products together with global sharing of the project results are important deliverables of the proposal for the current and future epidemics.

Call for proposal

H2020-SC1-PHE-CORONAVIRUS-2020-2

See other projects for this call

Sub call

H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT

Coordinator

IDRYMA TECHNOLOGIAS KAI EREVNAS
Net EU contribution
€ 252 000,00
Address
N PLASTIRA STR 100
70013 Irakleio
Greece

See on map

Region
Νησιά Αιγαίου Κρήτη Ηράκλειο
Activity type
Research Organisations
Links
Total cost
€ 252 000,00

Participants (7)